Oxygène Médicinal Liquide Vivisol (Oxygen)

Oxygen, the active ingredient in Oxygène Médicinal Liquide Vivisol, is a medical gas presented as a liquid for inhalation use. It supports respiratory function in patients with compromised oxygenation. GNH USA supplies Oxygène Médicinal Liquide Vivisol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Oxygène Médicinal Liquide Vivisol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Oxygène Médicinal Liquide Vivisol is a medical gas used in respiratory support and oxygen therapy pathways. - Acute hypoxemia: Improves arterial oxygen saturation in patients with sudden low blood‑oxygen levels. - Chronic obstructive pulmonary disease (COPD): Assists in maintaining adequate oxygenation during exacerbations. - Peri‑operative care: Provides supplemental oxygen to support ventilation during and after surgery. - High‑altitude exposure: Helps prevent hypoxic symptoms in individuals at high altitude. - Neonatal resuscitation: Supplies essential oxygen to newborns with respiratory distress. - Palliative care: Relieves dyspnea in terminally ill patients requiring comfort oxygen.

Oxygène Médicinal Liquide Vivisol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Dry mouth: Mild irritation of the oral mucosa. - Nasal irritation: Redness or soreness of nasal passages. - Cough: Transient irritation of the airway. - Headache: Mild headache related to changes in gas composition. - Fatigue: General tiredness during initial therapy.

Serious or Rare Side Effects: - Fire hazard: Increased risk of combustion in the presence of high‑flow oxygen. - Pulmonary edema: Fluid accumulation in the lungs in susceptible individuals. - Oxygen toxicity: Central nervous system effects with prolonged high concentrations. - Hypercapnia: Retention of carbon dioxide in patients with hypoventilation. - Barotrauma: Lung injury from excessive pressure during delivery. - Vision changes: Temporary visual disturbances in rare cases.

When using Oxygène Médicinal Liquide Vivisol, follow established safety and handling guidelines. - Patient assessment: Verify indication and baseline oxygen saturation before initiation. - Flow rate selection: Adjust to maintain target SpO2 levels as prescribed. - Monitoring: Continuously observe for signs of hypoxia or hyperoxia. - Contraindications: Avoid in patients with known oxygen sensitivity or fire‑hazard environments. - Storage: Store below 25°C: keep in the original container, protect from direct sunlight and moisture.

Oxygène Médicinal Liquide Vivisol may interact with other therapies that affect respiratory function or gas exchange.

Major Interactions (Avoid): - Nitrous oxide: Combined use can increase fire risk and alter gas dynamics. - High‑flow nasal cannula with heated humidifier: May cause excessive airway moisture and impair oxygen delivery.

Moderate Interactions (Monitor Closely): - Sedatives and opioids: May depress respiratory drive, requiring closer SpO2 monitoring. - Bronchodilators: May alter airway resistance, affecting oxygen distribution. - Positive pressure ventilation: Adjust settings to prevent barotrauma when supplemental oxygen is added. - Anesthetic gases: Coordinate concentrations to maintain safe inspired oxygen fractions. - Antioxidant supplements: Theoretical risk of altered oxidative balance; monitor patient response.